| INTRODUCTION
Eosinophilic gastrointestinal disorders (EGIDs) are an expanding entity of food hypersensitivities and constitute a diverse group of disorders with increased eosinophil counts in one or more parts of the gastrointestinal tract. 1 Eosinophilic oesophagitis (EoE) is the most common form of EGIDs in humans, with symptoms related to eosinophil-predominant mucosal inflammation and oesophageal dysfunction. 2 Recommendations in diagnostics, genetics, allergy testing, therapeutics and disease complications have been published by various work groups. [2] [3] [4] Patients have high rates of concurrent food sensitivities, 5 and it has been recently reported by Hill et al that 68% of EoE patients have IgE-mediated food allergy. 6 Elimination diet/ amino-acid feedings are one of the mainstays of treatment in young children. 7 Diagnostic criteria for other EGIDS, including eosinophilic gastritis, are less well defined, but Caldwell et al 8 neous immunotherapy (EPIT) in peanut allergic children, 9 we have decided to investigate the impact of EPIT on EGIDs.
First, to address the treatment of EoE and more largely EGIDs,
we developed a mouse model of esophago-gastro-enteropathy by sensitizing mice to peanut proteins and then feeding extensively with peanuts. By treating them just before the peanut oral feeding, we showed that EPIT protected previously peanut-sensitized mice from the eosinophilic mucosal infiltration seen in mice fed peanut 53 48 39 25 18 146 SensiƟzaƟon to peanuts (ip.) F I G U R E 1 Study design. Eighteen piglets are sensitized to peanut protein extract (PPE) by 3 intra-peritoneal (ip) injections at 1-week interval each and eight naive animals are also included in the study. PPE introduction into the diet is started at day 53 for 10 consecutive days and then endoscopy is performed to assess injuries in the upper digestive tract (from oesophagus until stomach). Epicutaneous immunotherapy (EPIT) is performed for 3 mo by applying active (n = 8) or placebo (n = 8) patches daily and renewed every 24 h. At the end of EPIT, animals are all exposed to the PPE diet daily. Endoscopy is performed at day 157 and killed at day 160 compared to untreated mice. 10 As presented in Figure 1 , sixteen piglets were sensitized using PPE were then re-exposed to the same PPE formula (day 150 to day 159), and the oesophagus and stomach were re-evaluated endoscopically.
Eight naive animals (controls) followed the same scheme, with intra-peritoneal injection of alum buffer and oral challenge with the oily matrix devoid of PPE.
Three days before killing, a peanut atopy patch test (APT) was applied for 48 hours on the outer part of left ear of each piglet (EPIT, placebo, control), and skin samples taken after killing (ie, 24 hours after removal) and preserved in formol for HE staining. Animals were killed after overnight fast, at day 160, the day following the end of oral PPE exposure. Oesophagus, stomach, duodenum and jejunum were taken for histological analysis and mRNA expression of cytokines and transcription factors. Blood samples were taken every month during EPIT and at the end of PPE oral exposure to measure the evolution of IgE.
| Reagents
Peanut protein extract (lyophilized extract; Greer Laboratories, Lenoir, North Carolina, USA) was used for sensitization and immunotherapy.
Commercial peanut oil (commercial organic food, France) was used for dilution of PPE to perform sustained food exposure. Viaskin â patches (DBV Technologies, Montrouge, France) were used for the immunotherapy treatment and contained PPE (100 lg, active group, EPIT) or buffer formulation (no proteins, non-active group; Placebo).
| Endoscopy and biopsy samples histology
At days 63 and 157, animals fasted overnight were anesthetized by ip injection of ketamine (22 mg/kg) and) + acepromazine (1.1 mg/ kg). Oesophagus and stomach were examined by endoscopy, and biopsies were performed. All endoscopic procedures were performed by an endoscopist blinded to case/control status. Oesophagus and stomach were carefully evaluated, and lesions were scored: Grade 0:
no lesion/Grade 1: slight gastritis/Grade 2: moderate gastritis/Grade 3: severe gastritis. 
| Collection of tissues
Oesophagus, stomach, duodenum, jejunum and skin were fixed either in 4% neutral-buffered formalin or in liquid nitrogen and prepared for analysis as previously described. 10 Three sections of each tissue were analysed by a pathologist blinded to piglet treatment group. Eosinophilic inflammation was scored as follows: (i) rare spread of eosinophils; (ii) local increase of eosinophils density;
(iii) diffuse increase with eosinophilic pseudo-abscess. Eosinophils were counted on haematoxylin-eosin-saffron stained sections by the pathologist, and results were expressed as number of eosinophils per mm 2 .
| Immune parameters
Spleen was sampled similarly for each animal, and the longitudinal central section was taken and cut into small pieces of 1 cm 2 each.
Pieces of spleen were used for mRNA analysis. Total RNA from spleen was extracted using RNeasy Mini Kit (Qiagen, Courtaboeuf, France) as previously described. 10 The pig primer sequences were previously described. 12 qPCR was performed using an ABI Prism 7300 sequence detector system (Applied Biosystems, Villebon-surYvette, France) using SYBR-green fluorescence (Master Mix Quantifast Syber Green; Qiagen) for quantification. Results were presented as mRNA expression in the control, placebo and EPIT groups.
Target gene expression was calculated relative to the expression of PPIA in each experimental sample, using the DCq method. Each set of quantitative PCR reactions were also run with negative controls without RNA and without RT.
Blood was collected following sensitization and after the treatment period. Sera were stored at À20°C until analyzed. IgE levels were determined by ELISA as described previously using a commercial kit and following the manufacturer's instructions (Porcine IgE ELISA kit; Bio-Medical Assay, Beijing, China).
| Statistical analysis
All statistical analyses were performed using the GraphPad Prism 3 | RESULTS
| Study adherence and clinical observations
Four piglets died before the end of the study but no death was directly related to the epicutaneous treatment. One sensitized animal died at 31 days (after sensitization but before peanut introduction in diet) due to piglet wasting disease. Two animals died at 63 days subsequently to anaesthesia and endoscopy. Those animals were randomized to placebo group. One EPIT animal died at 154 days due to a rectal prolapse, requiring subsequent euthanasia.
One naive and one sensitized piglets could not be evaluated during the first endoscopy due to anaesthesia and/or endoscopy issue.
We evaluated the weight of piglets over the treatment and peanut re-exposure phases. There were no differences in symptoms, feeding or behaviour (data not shown).
| Oral peanut exposure induces gastric lesions in peanut-sensitized piglets
Sensitized piglets developed severe gastric lesions after 10 days of oral PPE exposure (Figure 2 ). The score of macroscopic signs of inflammation in the stomach during endoscopy was significantly greater than in controls (P < .01).
| EPIT decreases gastric inflammation and gastric eosinophilia
Epicutaneous immunotherapy decreased the macroscopic signs of inflammation triggered in the stomach by PPE exposure (P = .0729, Figure 3A ), in contrast to the severe lesions observed in the placebo-treated group, with ulcers present in 2/8 animals. Endoscopic analysis, as illustrated in Figure 3D -F, revealed less inflamed mucosa in the EPIT-treated group compared to the placebo group, with a nodular appearance suggesting the recovery of inflamed mucosa.
Epicutaneous immunotherapy also reduced the histologic score 
| EPIT improves immunological parameters
Sensitization of the two groups of piglets was associated with an increase in total IgE (P < .001 vs control) (Figure 4) . Following EPIT and oral exposure to PPE, total IgE was significantly lower than in placebo animals (P < .05).
The expression of transcription factors (GATA-3, Tbet and Foxp3) and Th2 cytokines/chemokines involved in the eosinophilic disorders (IL-5, IL-13 and eotaxin) was assessed in spleens ( Figure 5 ).
The relative expression of GATA-3 was increased in sensitized (placebo-treated group) compared to naive animals (P < .05). EPIT significantly decreased the expression of GATA-3 and FOXP3 compared to placebo (respectively, P < .01 and P < .05). Moreover, EPIT significantly decreased the expression of IL-5 and eotaxin compared to placebo (respectively, P < .01 and .05). There was no major modification for IL-13, probably due to the heterogeneity of response in the placebo group.
No change was observed in Tbet expression in spleen either during sensitization or the period of epicutaneous immunotherapy.
Unfortunately, quantification of gene expression from the majority of samples obtained from the oesophagus, stomach, duodenum and jejunum could not be determined satisfactorily and in a viable manner, as gene expression was below the level of detection of the PCR device. 
| DISCUSSION
Herein we report both an original model of EGID, piglets sensitized to PPE exhibiting gastric eosinophilia following sustained oral exposure to peanut, and an original therapeutic approach in this disorder -EPIT.
For human eosinophilic gastrointestinal diseases (EGIDs), foods
have been shown to be causative in both children and adults with eosinophilic oesophagitis (EoE). However, there is less evidence for foods causing eosinophilic gastroenteritis. One abstract by Gonsalves and one manuscript by Ko showed that the six-food elimination and elemental diets were successful to a similar degree when compared to EoE. 13, 14 Furthermore, there are three case reports of milkinduced eosinophilic gastroenteritis. [15] [16] [17] Recently, EcheverriaZudaire et al 18 have described a case series of Spanish subjects that developed EGIDs during milk and/or egg OIT. In our piglet model, we have developed a peanut sensitive gastric eosinophilia to mimic food-induced EGIDs.
Previous studies have assessed the effects of food on the oesophagus and jejunum in sensitized mice. [19] [20] [21] A human scale animal model was needed to test the feasibly of EPIT in humans. In immunotherapy, might be due, at least in part, to genetic differences.
The protocol of intra-peritoneal sensitization was optimized in a preliminary experiment (data not shown) based on published methods. [22] [23] [24] And animals were maintained on a peanut-free diet to more closely mimic the elimination diet that is prescribed to EGID patients. 2, 25 The allergen, mixed with peanut oil favouring the contact of peanut proteins to the digestive mucosa, was subsequently reintroduced at the end of the sensitization period to mimic the natural course in man. Although the extensive exposure to the matrix may induce slight gastritis in 50% of control animals, the reintroduction of allergen into the diet of sensitized animals resulted in a model of stomach injuries, observed and scored by endoscopy.
Lesions were exclusively localized to the stomach, without any injuries or eosinophil infiltration observed in the oesophagus or the jejunum. A significant increase in total IgE was concomitantly observed in sensitized animals. Several assays were attempted to detect peanut-specific IgE by coating the ELISA plate with peanut and using the secondary antibody provided in total IgE kit or using an antihuman IgE. Unfortunately, high background levels prevented the reliable detection of peanut-specific IgE. However, despite the lack of measurement of specific IgE, it may be hypothesized that this increase reflected at least partially the peanut-specific IgE increase depicted in animal models of sensitization. 10, 26, 27 RT-qPCR performed on spleen samples showed significantly higher mRNA levels of GATA-3, IL-5 and eotaxin, which are likely involved in the pathogenesis of eosinophilic gastritis. Despite the severity of lesions induced by the PPE regimen, EPIT appeared efficacious, indicating that animals became less sensitive to PPE exposure, in agreement with our previous study in a mouse 
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F I G U R E 3 A, Endoscopy score, (B) Eosinophil score in stomach samples, (1: rare spread of eosinophils, 2: local increase in eosinophil density, 3: diffuse increase with eosinophilic micro-abscess), (C) counting of eosinophil infiltration by pathologist after HE staining. Endoscopy illustration for (D) control, (E) placebo and (F) epicutaneous immunotherapy (EPIT) treated groups. Individual data are plotted as the median value for each group. *P < .05 and **P < .01 (n = 8 control, 5 placebo and 7 EPIT) ** * * Total IgE F I G U R E 4 Immunological parameters: total serum IgE following sensitization, epicutaneous immunotherapy (EPIT), and allergen provocation measured in plasma. Data are expressed as the medians and interquartile ranges. *P < .05, **P < .01 (n = 8 control, 5 placebo and 7 EPIT) model of eosinophilic oesophagitis. 10 In the mouse model, EPIT prevented the eosinophilia and oesophageal inflammation after sustained oral exposure to peanut, whereas in the present study, EPIT appeared to reverse the lesions induced by the PPE regimen, as measured by all parameters. Further confirmation was observed by the decrease in mRNA expression of GATA-3, likely linked to the expression of Th2 cytokines, which participate in the pathogenesis of EGID. Interestingly, Foxp3 mRNA was significantly decreased by EPIT, indicating that either this transcript may be linked to Foxp3 + eosinophils (ie, less suppressive eosinophils are needed to counterbalance T cell infiltrate or their immunoregulatory function was restored) or lower Tregs were necessary to counteract the inflammatory process of eosinophilic gastritis. 7, 8 On the other hand, EPIT had no effect on the expression of Tbet mRNA, as already observed in our mouse model. 10, 26 In contrast to our findings, Akei et al, 30 and Venturelli et al 31 suggest that epicutaneous exposure to allergens could prime gastrointestinal injuries, especially EoE, via a Th2-dependant mechanism.
This sensitization/desensitization role of the skin has been addressed in previous studies and seems particularly linked to the integrity of the superficial layer of the skin (ie, the stratum corneum). 10, 32 In the present study, total IgE (increased by the sensitization process) was promote a specific T regulatory cell response not only at the draining lymph node, 32 but also at the systemic level, thus reaching the skin, the gut immune system and other organs. 33, 35 A similar decrease in eosinophilic inflammation on the skin after an APT was observed in our model of peanut-sensitized mice (unpublished data).
Eosinophilic oesophagitis is usually considered to be associated with 6 food allergens (especially milk, wheat, egg, and soy) 7, 36 In conclusion, we developed an original model of PPE exposure in piglets sensitized to PPE resulting in GE. This model was then used to assess the efficacy of EPIT, which desensitized peanut-sensitized piglets with severe eosinophilic inflammation in the stomach.
This study may open the way to a specific immunotherapeutic approach in allergy-induced diseases, especially EGIDs. Further studies will be necessary to confirm that EPIT is an effective form of therapy. 
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